A Study of Serumalt, Ast And Ggt (Hepatic Markers) In Patients With Chronic Alcoholic Liver Diseases In Tertiary Level Care Hospital
DOI:
https://doi.org/10.37506/fkz2g630Keywords:
Chronic alcoholic liver diseases, SerumALT, AST, GGT.Abstract
- BACKGROUND: Excessive alcohol consumption and consequent medical disorders are considerable problems in many countries. Aminotransferases (alanine aminotransferase ALT and aspartate aminotransferase AST) are the liver enzymes commonly used for detecting excessive drinking. Gamma-glutamyl transferase (GGT) is a membrane-bound glycoprotein enzyme widely used as an index of excessive ethanol intake. The aim of this study is to determine the changes in levels of ALT,AST and GGT in chronic alcoholic liver diseases.
- MATERIALS AND METHODS: A cross-sectional study was done and included 100 individuals (50 chronic alcoholic liver diseases cases and 50 normal controls). Serum ALT, AST, GGT were estimated by colorimetric method on fully automated chemistry analyzer.
- RESULT: Data were fed under Microsoft Excel 2007 and statistically analyzed by Graphpad software; Version 6.0, which evaluated the differences of various parameters in both groups on the basis of p value. Serum ALT, AST & GGT levels were significantly elevated in chronic alcoholic liver diseases patients as compared to normal healthy controls.
- CONCLUSION: Chronic consumption of alcohol results in the secretion of pro-inflamatory cytokines(TNF alpha, Interleukin 6 [IL6] and Interleukin 8 [IL8]),oxidative stress, lipid peroxidation, and acetaldehyde toxicity. These factors cause inflammation, apoptosis and eventually fibrosis of liver parenchyma which leads to elevations in liver enzymes like AST & ALT. GGT is an enzyme produced in the bile duct. Measurement of GGT is an extremely sensitive test. It is induced by alcohol and its serum activity may be increased in heavy drinkers even in the absence of liver damage or inflammation. Hence these parameters should be regularly monitored in chronic alcoholic liver diseases
References
Johanna Hietala.Novel Use of Biomarkers and Their Combinations for Detecting Excessive Drinking, University of Tampere, Medical School Seinajoki Central Hospital, Department of Laboratory Medicine and Medical Research Unit, Finland,2007: pp 15.
Peterson K. Biomarkers for alcohol use and abuse- A summary. Alcohol Res Health 2004-2005; 28(1):30-37.
Conigrave KM, Davies P, Haber P et al. Traditional markers of excessive alco-hol use. Addiction 2003; 98 (2): 31-43.
Harper’s Illustrated Biochemistry; 27th edition: Chapter 25, Page no: 217 229.
Chrostek L, Cylwik B, Szmitkowski M et al. The diagnostic accuracy of carbohy¬drate-deficient transferrin, sialic acid and commonly used markers of alcohol abuse during absti¬nence. Clin Chim Acta 2006; 364: 167-171.
Boris Tabakoff, Anders Helander, Kate M. Conigrave. WHO/ISBRA Study on State and Trait Markers in Alcoholism: The WHO/ISBRA Collaborative Project. Alcoholism: Clinical and Experimental Research 2001; 25: 99–103.
Daniela Ionescu, B.Bumbacila, Carmen Cristescu, Raluca Dumache et al. Carbohydrate-Deficient Transferrin and Gamma Glutamyl Transpeptidase- Marker of excessive alcohol consumption. Romanian J. Biophys 2008; 18; 301–307.
Dr.J.b Gogoi, Dr. Praveen k.Tyagi, Dr. Amit k.Singh et al. Study of serum gamma glutamyl transferase as a diagnostic marker in alcoholic hepatitis. IOSR Journal of Pharmacy (IOSRPHR) 2012; 2; 69-71.
Zein, M. and Discombe, G. Serum gamma-glutamyl transpeptidase as a diagnostic aid. The Lancet 1970; 296: 748–750.
B. Usharani, R. Vennila, N. Nalini et al. Biochemical changes in Alcoholics – A case control study. International Journal of Research in Pharmaceutical and Biomedical Sciences 2012; 3: 201-205.
Felver ME, Merzey, Herlong HF et al. Plasma tumor necrosis factor, a predicts decreased longterm survival in severe alcoholic hepatitis. Alcohol Clin. Exp Res.1990; 31: 117-134.
Tuma DJ. Serial review: Alcohol, oxidative stress and cell injury free. Radi. Biol. Med 2002; 32: 303-308.
Vajro P, Lofrano MM, Fontanella A and Fortunato G et al. Immunoglonulin complexed AST (“macro-AST”) in an asymptomatic child with persistent hypertansaminasemia. J Pediatr Gastroenterol Nutr. 1992; 15: 458-60.
Keeffe EB, Sunderland MC, Gabourel JD et al. Serum gamma-glutamyl transpeptidase activity in patients receiving chronic phenytoin therapy.Dig Dis Sci. 1986; 31(10): 1056-61.
Turecky L, Kupcova V, Szantova M, et al. Serum magnesium levels in patients with alcoholic and non-alcoholic fatty liver. Bratisl Lek Listy. 2006; 107(3): 58-61.
Subir Kumar Das, Prasunpriya Nayak, D.M.Vasudevan et al. Biochemical markers for alcohol consumption. IJCB 2005, 20(1): 35-42.
Downloads
Published
Issue
Section
License
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
https://creativecommons.org/licenses/by-nc/2.0/deed.en